{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:00:22Z","timestamp":1760385622522},"reference-count":15,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,2]]},"DOI":"10.14745\/ccdr.v43i11a02","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T19:36:16Z","timestamp":1519241776000},"page":"220-223","source":"Crossref","is-referenced-by-count":13,"title":["Enhancing antimicrobial stewardship by strengthening the veterinary drug regulatory framework"],"prefix":"10.14745","volume":"43","author":[{"given":"M","family":"Mehrotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X-Z","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MJ","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5795","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"key":"key20180221143553_r1","unstructured":"Government of Canada. Antimicrobial Resistance and Use in Canada: A Federal Framework for Action. Public Health Agency of Canada, Ottawa ON: 2014. https:\/\/www.canada.ca\/content\/dam\/canada\/health-canada\/migration\/healthy-canadians\/alt\/pdf\/drugs-products-medicaments-produits\/buying-using-achat-utilisation\/antibiotic-resistance-antibiotique\/antimicrobial-framework-cadre-antimicrobiens-eng.pdf"},{"key":"key20180221143553_r2","unstructured":"Government of Canada. Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action. https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/drugs-health-products\/tackling-antimicrobial-resistance-use-pan-canadian-framework-action.html"},{"key":"key20180221143553_r3","unstructured":"Health Canada. Guidance for Industry Preparation of Veterinary New Drug Submissions. Ottawa ON: 2007. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/veterinary-drugs\/legislation-guidelines\/guidance-documents\/guidance-industry-preparation-veterinary-new-drug-submissions-health-canada-2007.html"},{"key":"key20180221143553_r4","unstructured":"Health Canada. Categorization of Antimicrobial Drugs Based on Importance in Human Medicine. Ottawa ON: 2009. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/veterinary-drugs\/antimicrobial-resistance\/categorization-antimicrobial-drugs-based-importance-human-medicine.html"},{"key":"key20180221143553_r5","unstructured":"Health Canada. Uses of Antimicrobials in Food Animals in Canada: Impact on Resistance and Human Health. Advisory Committee on Animal Uses of Antimicrobials and Impact on Resistance and Human Health. Report Prepared for Veterinary Drugs Directorate, Health Canada. Ottawa ON: 2002. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/reports-publications\/veterinary-drugs\/uses-antimicrobials-food-animals-canada-impact-resistance-human-health-health-canada-2002.html"},{"key":"key20180221143553_r6","unstructured":"World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. WHO, Switzerland: 2001. http:\/\/www.who.int\/drugresistance\/WHO_Global_Strategy_English.pdf"},{"key":"key20180221143553_r7","unstructured":"World Organisation for Animal Health. OIE International Standards on Antimicrobial Resistance. OIE, Paris, France: 2003. http:\/\/www.oie.int\/doc\/ged\/D9769.pdf"},{"key":"key20180221143553_r8","unstructured":"Office of the Auditor General of Canada. Report 1 \u2013 Antimicrobial Resistance. Ottawa ON: 2015. http:\/\/www.oag-bvg.gc.ca\/internet\/English\/parl_oag_201504_01_e_40347.html"},{"issue":"27","key":"key20180221143553_r9","first-page":"2357","article-title":"Regulations Amending the Food and Drug Regulations (Veterinary Drugs \u2013 Antimicrobial Resistance)","volume":"150","author":"Government of Canada","year":"2016","journal-title":"Can Gaz, I"},{"issue":"10","key":"key20180221143553_r10","first-page":"942","article-title":"Regulations Amending the Food and Drug Regulations (Veterinary Drugs \u2013 Antimicrobial Resistance)","volume":"151","author":"Government of Canada","year":"2017","journal-title":"Can Gaz, II"},{"key":"key20180221143553_r11","unstructured":"Government of Canada. Antibiotic Resistance and Animals. Ottawa ON: 2017. https:\/\/www.canada.ca\/en\/public-health\/services\/antibiotic-antimicrobial-resistance\/animals.html"},{"key":"key20180221143553_r12","unstructured":"Government of Canada. Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2014 Annual Report. Public Health Agency of Canada, Guelph ON: 2016. http:\/\/www.phac-aspc.gc.ca\/cipars-picra\/pubs-eng.php"},{"key":"key20180221143553_r13","unstructured":"Codex Alimentarius Commission. Code of Practice to Minimize and Contain Antimicrobial Resistance (CAC\/RCP 61-2005). 2005. www.fao.org\/input\/download\/standards\/10213\/CXP_061e.pdf"},{"key":"key20180221143553_r14","unstructured":"Canadian Food Inspection Agency. Compendium of Medicating Ingredient Brochures. Ottawa ON: 2017. http:\/\/www.inspection.gc.ca\/animals\/feeds\/medicating-ingredients\/eng\/1300212600464\/1320602461227"},{"key":"key20180221143553_r15","unstructured":"Government of Canada. Federal Action Plan on Antimicrobial Resistance and Use in Canada: Building on the Federal Framework for Action. Public Health Agency of Canada, Ottawa ON: 2015. https:\/\/www.canada.ca\/content\/dam\/canada\/health-canada\/migration\/healthy-canadians\/alt\/pdf\/publications\/drugs-products-medicaments-produits\/antibiotic-resistance-antibiotique\/action-plan-daction-eng.pdf"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2017-43\/ccdr-volume-43-11-november-2-2017\/ccdr-43-11-mehrotra-eng.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T18:41:27Z","timestamp":1521744087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2017-43\/ccdr-volume-43-11-november-2-2017\/ccdr-43-11-mehrotra-eng.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,2]]},"published-print":{"date-parts":[[2017,11,2]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v43i11a02","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11,2]]}}}